Search results
Author(s):
Paul S Chan
Added:
3 years ago
Sudden cardiac death (SCD) is the leading cause of mortality in patients with ischemic heart disease and left ventricular dysfunction.1 The second Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) have shown that implantable cardioverter defibrillators (ICDs) reduce mortality in patients with ischemic heart disease and…
View more
Author(s):
Paul S Chan
Added:
3 years ago
Sudden cardiac death (SCD) is the leading cause of mortality in patients with ischemic heart disease and left ventricular dysfunction.1 The second Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) have shown that implantable cardioverter defibrillators (ICDs) reduce mortality in patients with ischemic heart disease and…
View more
Federico M Asch
Job title: Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine
Author
Author(s):
Darwin Jeyaraj
,
David S Rosenbaum
Added:
3 years ago
Heart disease is the leading cause of death in the US with 700,000 deaths annually, of which 460,000 are attributable to sudden cardiac death (SCD). SCD is usually attributed to ventricular fibrillation (VF). Despite recent reductions in cardiac mortality from other causes, the incidence of SCD remains high with minimal decline in the last decade. The large majority of patients who suffer life…
View more
Author(s):
Essa Hariri
,
Anna Scandinaro
,
Mazen M Al Hammoud
,
et al
Added:
1 year ago
Author(s):
Timothy M Markman
,
Daniel A McBride
,
Jackson J Liang
Added:
3 years ago
Ventricular tachycardia (VT) occurs most frequently in patients with structural heart disease. Management of VT in these patients can be complex, requiring an integrated approach with multiple therapeutic modalities. Antiarrhythmic drugs (AADs) can be effective in the management of VT and implantable cardioverter defibrillators (ICDs) have been shown to effectively prevent sudden cardiac death…
View more
Author(s):
Harriette Van Spall
,
Divaka Perera
,
Peter O’Kane
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principle investigator, Dr Divaka Perera (King’s College London & Guy’s & St Thomas’ Hospital, UK) and investigator, Dr Peter O'Kane (Royal Bournemouth Hospital, UK) to discuss the REVIVED-BCIS2 viability analysis (NCT01920048).
This analysis of the REVIVED-BICS2 trial found that viability…
View more
Author(s):
David S Rosenbaum
Added:
3 years ago
Heart disease is the leading cause of death in the US with 700,000 deaths annually, of which 460,000 are attributable to sudden cardiac death (SCD).1,2 SCD is usually attributed to ventricular fibrillation (VF). Despite recent reductions in cardiac mortality from other causes, the incidence of SCD remains high with minimal decline in the last decade. The large majority of patients who suffer life…
View more
Author(s):
Thomas J Povsic
Added:
3 years ago
The potential of physiological regeneration offered by stem-cell-mediated therapy has captured the imagination of both the public and the scientific community. This is especially true for the cardiovascular and nervous systems, which have long been considered terminally differentiated and post-mitotic with minimal capacity for regeneration and repair.
While the ability of embryonically derived…
View more
Author(s):
Yasmin S Hamirani
,
Hussain Isma’eel
,
Irfan Zeb
,
et al
Added:
3 years ago
The prevalence of heart failure and the resultant mortality has continued to rise despite increased understanding of the pathogenesis and improvement in management strategies.1 Left ventricular (LV) dysfunction is the final stage of most primary cardiovascular diseases, and greater severity is directly correlated with worse prognosis. The principal manifestation of heart failure progression is a…
View more